Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C

Liver Transplantation

Volumn 9, Issue 11, 2003, Pages S1-S9

  Wiesner, Russell H ^a   Sorrell, Michael ^a   Villamil, Federico ^a   Balan, Vijayan ^a   Berenguer, Marina ^a   Brown, Robert S ^a   Charlton, Michael R ^a   Davis, Gary I ^a   Dickson, Rolland C ^a   Everson, Gregory T ^a   Freeman, Richard B ^a   Gane, Edward J ^a   Ghobrial, R Mark ^a   Gordon, Fredric ^a   Kuo, Paul ^a   Lake, John R ^a   Marcos, Amadeo ^a   Mason, Andrew ^a   McCashland, Timothy ^a   McCaughan, Geoffrey W ^a   Miller, Charles ^a   Neuberger, James ^a   Neuhaus, Peter ^a   Poterucha, John J ^a   Rakela, Jorge L ^a   Rodes, Juan ^a   Rosen, Hugo R ^a   Schiff, Eugene R ^a   Shaw, Byers W ^a   Shiffman, Mitchell L ^a   Terrault, Norah ^a   Trotter, James ^a   Vierling, John M ^a   Wall, William J ^a   Wright, Teresa L ^a   more..

^a International Liver Transplantation Society Expert Panel on Liver Transplantation and HCV   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INTERFERON; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; POLYCLONAL ANTIBODY; PREDNISONE; RAPAMYCIN; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ANEMIA; ANTIVIRAL ACTIVITY; BONE MARROW SUPPRESSION; CONFERENCE PAPER; CYTOPENIA; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG COMBINATION; DRUG EFFICACY; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MEDICAL EXPERT; MEDICAL SOCIETY; NEUTROPENIA; ORGAN DONOR; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; RECURRENT VIRUS INFECTION; REOPERATION; RISK FACTOR; SYMPOSIUM; THROMBOCYTOPENIA; VIROLOGY;

ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HEPATITIS C; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PATIENT SELECTION; PRACTICE GUIDELINES; RECURRENCE; REOPERATION; RIBAVIRIN; RISK FACTORS;

EID: 10744233398     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50268     Document Type: Note

References (0)